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MicroRNAs (miRNAs) are 19 to 23 nucleotide–long RNAs that post-transcriptionally regulate gene expression. Human
cells express several hundred miRNAs which regulate important biological pathways such as development,
proliferation, and apoptosis. Recently, 12 miRNA genes have been identified within the genome of Kaposi sarcoma–
associated herpesvirus; however, their functions are still unknown. To identify host cellular genes that may be targeted
by these novel viral regulators, we performed gene expression profiling in cells stably expressing KSHV-encoded
miRNAs. Data analysis revealed a set of 81 genes whose expression was significantly changed in the presence of
miRNAs. While the majority of changes were below 2-fold, eight genes were down-regulated between 4- and 20-fold.
We confirmed miRNA-dependent regulation for three of these genes and found that protein levels of thrombospondin
1 (THBS1) were decreased .10-fold. THBS1 has previously been reported to be down-regulated in Kaposi sarcoma
lesions and has known activity as a strong tumor suppressor and anti-angiogenic factor, exerting its anti-angiogenic
effect in part by activating the latent form of TGF-b. We show that reduced THBS1 expression in the presence of viral
miRNAs translates into decreased TGF-b activity. These data suggest that KSHV-encoded miRNAs may contribute
directly to pathogenesis by down-regulation of THBS1, a major regulator of cell adhesion, migration, and
angiogenesis.
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Introduction
Kaposi sarcoma–associated herpesvirus (KSHV) is the
causative agent of Kaposi sarcoma (KS) and is associated
with primary effusion lymphoma (PEL) and a subset of
multicentric Castleman disease [1–4]. In KS tumors and PELs,
the majority of cells are latently infected and express only a
subset of viral genes located within the latency-associated
region [5,6]. Recently, 12 microRNA (miRNA) genes have
been identiﬁed within this region [7–9].
miRNAs are 19 to 23 nucleotide (nt)–long RNAs that post-
transcriptionally regulate gene expression through selective
silencing of target messenger RNAs (mRNAs). Precursor
miRNAs are expressed as hairpin structures from transcribed
RNA that are cleaved by Drosha, exported from the nucleus
through Exportin 5, and subsequently processed by Dicer.
Mature miRNAs are then incorporated into the RNA-induced
silencing complex (RISC), which guides their binding to
39UTRs of target mRNAs and sequesters them to processing
bodies, ultimately leading to inhibition of translation and
mRNA degradation (for review see [10]). Although target
recognition for miRNAs is not completely understood, a seed
sequence within the miRNA (nts 2 through 8) is known to be
critical for binding and target recognition. In this manner, a
single miRNA may regulate a large number of genes [11].
Human miRNAs have so far been found to regulate
fundamental biological processes such as developmental
pattern formation, hematopoiesis, apoptosis, and cell cycle
control (for review see [12]).
miRNAs have been identiﬁed within several DNA viruses,
including herpesviruses (for reviews see [13–15]). A total of 17
miRNAs, encoded by 12 miRNA genes, have been cloned from
KSHV-infected PEL cells, and interestingly, all are located
within the KSHV latency-associated region (Figure 1A). This
region encodes the latency-associated nuclear antigen (LA-
NA), v-Cyclin, v-Flip, and the kaposin gene family, all of which
modulate host cellular gene expression and signal trans-
duction in latently infected cells [6,16–21]. We hypothesize
that KSHV-encoded miRNAs target host/cellular gene ex-
pression and, as a result, play a role in viral pathogenesis.
As viral miRNAs have no sequence conservation to
metazoan miRNAs, we are able to study them through ectopic
expression without interfering with endogenous miRNAs. In
this study, we have stably expressed ten KSHV miRNA genes
in 293 cells and identiﬁed a total of 81 gene expression
changes by microarray expression proﬁling. We conﬁrmed a
subset of these by quantitative real-time (qRT)–PCR, lucifer-
ase knockdown experiments, and Western blot analysis.
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potent inhibitor of angiogenesis reported to be down-
regulated in KS lesions [22], as a target of multiple KSHV
miRNAs.
Results
Ectopic Expression of KSHV miRNAs in 293 Cells
KSHV miRNAs are coordinately expressed with the
latency-associated genes LANA, v-Cyclin, v-Flip, and kaposin,
which all modulate the host cellular environment in KS
tumors cells [6,16–21]. Hence, we hypothesized that KSHV-
encoded miRNAs target host/cellular gene expression and as a
result play a role in viral pathogenesis.
To identify potential miRNA targets without interference
from viral proteins, we introduced the miRNA cluster, which
encodes ten miRNA genes within a 2.8-Kbp (kilo–base pair)
region (nts 119,635 to 122,481; Figure 1A), into a cytomega-
lovirus promoter containing expression plasmid and stably
expressed the resulting construct or empty vector control in
293 cells. Cell populations rather than single-cell clones were
used for subsequent experiments to avoid the risk of
detecting expression differences caused by speciﬁc integra-
tion events.
To conﬁrm miRNA expression in stable 293 pmiRNA
cluster cells, we performed Northern blot analysis and
luciferase reporter de-repression assays. The expression level
of miR-K12–1 was about 20% compared to latently infected
PEL cells, which contain a high copy number of KSHV
episomes (Figure 1B). To detect individual miRNA expres-
sion, we performed luciferase reporter de-repression assays.
First, sensor constructs each containing two complementary
binding sites for a speciﬁc miRNA within the 39UTR of pGL3
were constructed for each miRNA. Co-transfection of these
constructs with individual miRNA expression vectors showed
a dose-dependent inhibition, conﬁrming sensor speciﬁcity
(Figure S1). Individual KSHV miRNA expression in stable 293
pmiRNA cluster cells was examined using 29OMe RNA
antagomirs against each miRNA, which inhibit miRNA-
containing RISC complexes in a sequence-speciﬁc manner
[ 2 3 , 2 4 ] .A ss e e ni nF i g u r e1 C ,a l ln i n em i R N As e n s o r
constructs show a dose-dependant de-repression between 2-
and 5-fold in the presence of 29OMe RNAs, conﬁrming
miRNA expression from the cluster.
Expression Profiling Revealed 81 Gene Expression
Changes in miRNA-Expressing Cells
For each cell line, 293 pmiRNA cluster and 293 vector
control, two independent cultures were harvested at two time
Figure 1. 293 miRNA Cluster Cells Express KSHV miRNAs
(A) Schematic diagram of the latency-associated region in the KSHV genome. The black bar indicates the miRNA cluster containing ten KSHV miRNA
genes (grey bars) that were inserted into the expression vector.
(B) Northern blot analysis of KSHV miRNAs in 293 pmiRNA cluster cells versus 293 pcDNA control cells and BCBL-1 cells. Total RNA (30 lg) was loaded
and hybridized to a probe for miR-K12–1. Ribosomal RNA (rRNA) is shown as a loading control.
(C) Luciferase de-repression assays show expression of all miRNAs within the cloned cluster in 293 pmiRNA cluster cells. The level of 29OMe RNA was
kept constant at 400 pmol with filler 29OMe targeting miR-K12–10, a KSHV miRNA not represented in the cluster. Luciferase sensor (200 ng) was
transfected along with the noted amounts of 29OMe RNA specific to that miRNA. Transient transfection assays were done twice in triplicate and
luciferase activity was normalized to total protein concentration. RLU, relative light units.
doi:10.1371/journal.ppat.0030065.g001
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Author Summary
Kaposi sarcoma–associated herpesvirus (KSHV) is a gamma-herpes-
virus associated with Kaposi sarcoma, primary effusion lymphoma,
and a subset of muticentric Castleman disease. Recently, it was
found that KSHV encodes 12 microRNAs (miRNAs) within its latency-
associated region. miRNAs are small ;22 nucleotide-long single-
stranded RNA molecules that act to inhibit gene expression by
binding to target messenger RNAs (mRNAs). Because miRNAs bind
to these targets with limited base pairing, it has been difficult to find
targets. The goal of our study was to identify cellular mRNAs
targeted by KSHV-encoded miRNAs. Microarray analysis of cells
expressing the KSHV miRNAs revealed a set of 81 genes that were
changed. Several genes are regulators of important functions such
as blood vessel growth, cell proliferation, and cell death. One target,
thrombospondin 1, is a potent inhibitor of blood vessel growth and
is known to be down-regulated in Kaposi sarcoma tumors.
Thrombospondin 1, which is targeted by multiple miRNAs, also
showed reduced protein levels in our study. To our knowledge, our
data describe the first targets for tumorvirus-encoded miRNAs and
suggest that these novel regulators may have roles in pathogenesis.points for a total of eight samples. RNA extraction,
quantiﬁcation, cRNA synthesis, hybridization, and washing
steps were done as recommended by the manufacturer and as
previously described [16,25].
Figure 2 shows the expression proﬁle of genes found to be
signiﬁcantly changed (p , 0.001) between both cell lines.
Probe sets (205) were identiﬁed representing 177 genes. Of
the 177 expression differences, the majority (137) showed
decreased expression, while 39 genes showed expression
increases. A cross validation (CV) analysis showed that of the
205 initial probe sets, a total of 81, representing 73 genes with
39UTRs, show 100% CV (Table S1). This analysis, based on t-
values of signal intensities, gives statistically robust data but
includes probe sets with relatively small fold changes. For the
ﬁnal data set, 65 genes were decreased in their expression
between 1.05- and 20.4-fold, while eight genes were increased
between 1.05- and 1.4-fold (Table S1). Eight genes showed
decreases greater than 4-fold. Interestingly, ﬁve of these
genes—SPP1 (osteopontin), THBS1, S100A2 (S100 calcium
binding protein A2), PRG1 (plasticity related gene 1) (now
named SRGN), and ITM2A (integral membrane protein 2A)—
have roles in processes such as proliferation, immune
modulation, angiogenesis, and apoptosis.
qRT-PCR and Bio-Statistical Analyses Validate Potential
Targets
Based on the CV support and high fold changes, we chose
six genes for qRT-PCR analysis. As seen in Table 1, the fold
changes observed with qRT-PCR closely match and validate
the microarray results.
To determine whether the microarray gene changes are
due to direct miRNA targeting, we scanned the 39UTRs of the
affected genes for potential miRNA binding sites. We initially
concentrated on the seed sequences of the miRNAs (nts 2
through 8), which are known to be critical determinants of
miRNA target recognition [11]. A similar analysis showed that
the presence of seed matches within 39UTRs for tissue-
speciﬁc miRNAs predicted low expression levels for the
corresponding genes [26]. In our analysis, we ﬁrst determined
the number of perfect and single mismatch seed matches for
each miRNA by scanning a total of 222,817 nts representing
116 39UTRs compiled from the Ensembl database (http://www.
ensembl.org). As controls, all 39UTR sequences were ran-
domly shufﬂed ten times, creating unrelated sequences with
conserved guanine-cytosine content, and seed match scans
were repeated for each shufﬂe. As an additional control, the
116 39UTRs were screened for Epstein Barr virus (EBV)–
encoded miRNA seed binding sites. EBV miRNAs lack
sequence homology to both human and KSHV miRNAs.
The frequency for perfect KSHV miRNA seed matches was
one in every 865 nts, compared to 1,358 nts for shufﬂed
sequences and 1,400 nts for unrelated EBV miRNAs (Table 2).
The observation that perfect seed matches for KSHV miRNAs
are signiﬁcantly (p , 0.05) enriched within the 39UTRs of
genes identiﬁed by microarray analysis indicates that these
genes are targeted by miRNAs.
39UTRs of SPP1, PRG1, ITM2A, S100A2, RAB27A, and
THBS1 were also scanned by miRanda [27], which predicted
high probability miRNA binding sites (scores above 190 and/
or free energy values below 20 kcal/mol) within their 39UTRs
(Figure S3). In particular, THBS1 was predicted to have 34
binding sites for 12 KSHV miRNAs. Together, the bio-
statistical analyses and the conﬁrmation by qRT-PCR strongly
suggest that the observed gene expression changes are due to
viral miRNA expression.
To test this directly, we inserted the 39UTRs of SPP1, PRG1,
or THBS1 into the pGL3 promoter vector downstream of the
Figure 2. miRNA Responsive Gene Expression Profiles
Colors represent changes in variance-normalized gene expression
differences for individual genes represented by the probe sets as
indicated on the color scale. The dendrogram denotes the relative
relationship among the significant probe sets (p , 0.001) among the
eight samples.
doi:10.1371/journal.ppat.0030065.g002
Table 1. Fold Changes for Selected Genes
Gene Microarray qRT-PCR
% CV Support Fold Change p-Value Fold Change
SPP1 100  20.44 1.00E-06  93.31
THBS1 100  6.10 3.20E-05  6.83
S100A2 100  5.03 2.00E-06  16.18
PRG1 100  4.27 1.00E-06  8.82
ITM2A 100  4.06 1.76E-04  4.54
RAB27A 100  1.35 3.11E-04  1.22
doi:10.1371/journal.ppat.0030065.t001
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Cellular Targets for KSHV MicroRNAsluciferase gene. Co-transfection of these constructs into 293
pmiRNA cluster cells with a mixture of ten 29OMe RNAs
resulted in signiﬁcant de-repression of luciferase activity as
compared with an unrelated control 29OMe RNA (Figure 3A).
These results show that the 39UTRs of SPP1, THBS1, and
PRG1 confer miRNA-dependent repression to a heterologous
reporter, further supporting that the observed expression
differences are miRNA-dependent.
Protein Levels of THBS1 Are Greatly Reduced in the
Presence of KSHV miRNAs
Western blot analysis was performed to determine whether
decreased mRNA levels for SPP1, S100A2, and THBS1 trans-
late into inhibition of translation and, subsequently, de-
creased protein abundance. As seen in Figure 3B, THBS1
expression was dramatically reduced (.10-fold) in KSHV
miRNA-expressing 293 cells when compared to vector
control. SPP1 and S100A2 protein levels were not affected
even though mRNA levels were decreased 20.4- and 5.1-fold,
respectively. Hence, for one out of three genes examined by
Western blot, we detected reduced protein levels in miRNA-
expressing cells.
KSHV miRNAs Repress THBS1 in BJAB Cells
To ensure that KSHV miRNA-mediated repression of
THBS1 is not a 293 cell line speciﬁc effect, we performed
transient transfection assays in BJAB cells. Either vector
control or miRNA cluster was transfected into BJAB cells
along with the THBS1 luciferase reporter. Luciferase readouts
showed a 2-fold reduction of luciferase in response to
expression of the miRNAs (Figure 3C). Thus, targeting of
THBS1 by KSHV-encoded miRNAs can be observed in 293
cells and in BJAB, a lymphoid cell line.
THBS1 Is Targeted by Multiple KSHV miRNAs
We next asked whether speciﬁc KSHV miRNAs may be
responsible for decreased THBS1 expression levels. We
performed luciferase de-repression assays by co-transfection
of the THBS1 39UTR reporter and 29OMe RNAs speciﬁc to
individual KSHV miRNAs. Our results demonstrate that
THBS1 is targeted by multiple KSHV miRNAs; in particular,
miR-K12–1, miR-K12-3-3p, miR-K12-6-3p, and miR-K12–11
lead to strong de-repression of the reporter (Figure 4A).
Interestingly, the observed de-repression levels closely match
with the number of miRanda-predicted high afﬁnity binding
sites (Figure S3) in that the four miRNAs with the highest
levels of repression also have the highest number of predicted
binding sites. It is important to note that we observed higher
levels of de-repression than those seen in Figure 3A.
However, although the total amount of 29OMe is the same
in both experiments, the concentrations of each individual
29OMe is 10-fold greater for Figure 4. As an additional
control we tested the 39UTR of HS6ST2 in the same assay
(Figure 4B). The 39UTR of HS6ST2 is 2,213 bp in length
(compared to 2,095 for THBS1), is shown to have no
expression change in response to the KSHV miRNAs via
microarray, and was predicted by miRanda to have few
miRNA binding sites (unpublished data). As shown in Figure
4B, HS6ST2 showed virtually no difference in luciferase
activity for all KSHV miRNAs, with the exception of miR-
K12-6-3p. These results show that the inhibition of THBS1 by
the KSHV miRNAs is speciﬁc. The reason for the 6-fold de-
repression with miR-K12-6-3p is not clear as there is only one
high afﬁnity binding site predicted for HS6ST2; however, the
de-repression shown with THBS1 is still greater than this.
Thus, our data suggest that THBS1 is targeted by multiple
KSHV miRNAs rather than a speciﬁc, individual viral miRNA.
Decreased THBS1 Protein Levels Translate into Reduced
TGF-b Activity
THBS1 is a matricellular glycoprotein with strong anti-
proliferative and anti-angiogenic activity that can activate the
latent form of TGF-b by direct binding through its RFK and
WxxW motifs [28,29]. We asked whether TGF-b activity is
decreased in cells that express KSHV miRNAs and, as a result,
have decreased levels of THBS1. To this end, we performed
transient transfection assays using two different TGF-b–
responsive promoters (Figure 5). SBE4 contains four Smad-
binding elements and is commonly used to detect active TGF-
b [30]. We also tested the native matrix metalloproteinase-9
promoter (MMP-9), which is activated in response to TGF-b
signaling [31]. Reporter vectors were transfected into 293
pmiRNA cluster or vector control cells and cell lysates
assayed for luciferase activity. Transcription from the SBE4
reporter was reduced 11-fold in cells expressing KSHV
miRNAs, while MMP-9 promoter activity was inhibited 2-
fold. It is important to note that transcript levels of both TGF-
b and Smad3 were not altered as determined by gene
expression proﬁling; thus, the decreased TGF-b activity is
not due to miRNA-dependent inhibition of TGF-b or Smad3.
These data demonstrate that decreased THBS1 protein levels
translate into downstream TGF-b signaling.
Discussion
miRNA genes have been identiﬁed in all herpesviruses
studied to date, and an important question remains as to how
these novel regulators contribute to viral biology. Viral
miRNAs may target viral and/or host cellular gene expression.
The fact that miRNAs are not conserved between virus
families suggests that each virus may have evolved to target
diverse sets of genes to aid its speciﬁc replication strategy
(i.e., tissue tropism for latent, lytic, and persistent infection).
Observations made on genetically modiﬁed KSHV viruses
suggest that most KSHV miRNAs are not required for lytic
replication in culture [32]. We hypothesized that KSHV
miRNAs, which are coordinately expressed within the
latency-associated region, modulate host cellular gene ex-
Table 2. Seed Matching Data Using an Ad Hoc Scanning
Algorithm
Category KSHV EBV
Native Shuffled Native
Total UTR length (nt) 135,880 135,880 135,880
Exact hits 157 100 97
Frequency exact 865.48 1,358.80 1,400.82
ANOVA p-value — 0.03 0.02
Mismatch hits 2,496 2,320.3 2,473
Frequency mismatch 54.44 58.56 54.95
ANOVA p-value — 0.64 0.95
doi:10.1371/journal.ppat.0030065.t002
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and persistence in the infected host.
One of the most problematic areas of miRNA biology is
identifying their targets and functions. Due to the rather
large number of human miRNAs and the limited homology
requirements for binding, in silico–based attempts for miRNA
target predictions have suggested a model by which thou-
sands of genes are targeted [11]. However, in contrast to the
genetically deﬁned roles of some Caenorhabditis elegans and
Drosophila melanogaster miRNAs, only a few vertebrate miRNA
targets have been determined [10,12,33].
This study aimed to experimentally determine cellular
genes targeted by virally encoded miRNAs. Ectopic expres-
sion of ten KSHV miRNA genes in 293 cells resulted in
signiﬁcant (p , 0.001) expression differences of 81 genes, 65
of which were down-regulated (Table S1). These results were
conﬁrmed by qRT-PCR and bioinformatics analyses, which
revealed a signiﬁcant enrichment for seed sequence matches
within the 39UTRs of genes changed (Tables 1 and 2).
Interestingly, the number of seed matches in our analyses
varied signiﬁcantly between miRNAs. For example, miR-K12–
1, K12-6-5p, and K12-9-5p show signiﬁcantly increased hits
and therefore may target more genes (Figure S2). In a related
study, Sood et al. recently demonstrated that this seed
sequence analysis is effective at predicting decreased ex-
pression levels for genes containing seed binding sites to
tissue-speciﬁc miRNAs [26].
While the majority of observed gene changes were
moderate decreases, eight genes showed greater than 4-fold
down-regulation, including SPP1, S100A2, ITM2A, PRG1, and
THBS1 (Table 1). We (i) conﬁrmed KSHV miRNA-dependent
inhibition of the 39UTRs of SPP1, PRG1, and THBS1 using
luciferase de-repression assays in the 293 miRNA cluster cells,
(ii) demonstrated inhibition of THBS1 in BJAB cells, and (iii)
found decreased protein levels for THBS1 in the presence of
KSHV miRNAs (Figure 3). Additionally, we observed that
Figure 3. KSHV miRNAs Down-Regulate Targets
(A) Luciferase de-repression assays were performed in 293 pmiRNA cluster cells using 200 ng of sensor vectors containing the 39UTRs of SPP1, PRG1, or
THBS1. Then, 400 pmol of either the 29OMe miR-K12–10 (control) or a mixture of 29OMe RNA (specific to miR-K12–1–miR-K12–9 and miR-K12–11) (40
pmol each) were added to each transfection.
(B) Western blot analysis of 293 pmiRNA cluster cells versus 293 pcDNA control cells.
(C) Transient luciferase assay in BJAB cells using 4.8 lg of either pcDNA3.1 empty vector or miRNA cluster expression vector and 200 ng of THBS1
luciferase sensor vector.
doi:10.1371/journal.ppat.0030065.g003
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Cellular Targets for KSHV MicroRNAsTHBS1 is targeted by multiple KSHV miRNAs, with the major
miRNA species being miR-K12–1, miR-K12-3-3p, miR-K12-6-
3p, and miR-K12–11 (Figure 4A). It is important to note that
the observed effects were speciﬁc to THBS1 since the 2,213-
bp HS6ST2 39UTR, although of comparable length, was not
similarly de-repressed. Multiple miRNAs have previously
been reported to target a single 39UTR. Stark et al. found
.50% of all predicted miRNA targets contain binding sites
for more than one miRNA and that as many as 12 different
miRNAs can target a single 39UTR [34]. Generally, genes that
require strict regulation have longer 39UTRs and thus more
binding sites for miRNAs. Additionally, for THBS1, miRanda
[27] predicted 34 high probability binding sites for 12
different KSHV miRNAs within the THBS1 39UTR (see Figure
S3). These bioinformatic predictions are well in agreement
with the levels of de-repression seen for individual miRNAs.
The fact that THBS1 has a long (2,095 bp) 39UTR and has
binding sites for multiple KSHV miRNAs suggests that
inhibition of THBS1 is important for KSHV biology.
To investigate the biological effects of altered THBS1
levels, we utilized TGF-b–responsive reporter constructs and
demonstrated decreased TGF-b activity (Figure 5). It is
important to note that transcript levels of TGF-b and Smad3
were not altered in response to miRNA expression; thus, the
decreased TGF-b activity is not due to miRNA inhibition of
TGF-b or Smad3.
Of those genes exhibiting the highest down-regulation in
response to miRNAs, ﬁve are involved in proliferation,
immune modulation, angiogenesis, and apoptosis pathways
often altered in cancer. SPP1 is a secreted phosphoprotein
also called osteopontin, which is known to interact with a
variety of integrins as well as with CD44, and plays a role in
cell-mediated immunity. SPP1 also has demonstrated anti-
proliferative activity against virally infected mucosal epithe-
lial cells [35,36]. S100A2 is a calcium-binding protein that is
down-regulated in many tumor types and is thought to
possess tumor suppressor activity. Additionally, S100A2
interacts with the p53 family proteins p67 and p73 and
increases transcriptional activity of p53 [37,38]. ITM2A is an
integral membrane protein that may play a role in selection
of T cells in the thymus and may also function in cartilage
development [39]. PRG1 is a granule proteoglycan secreted by
hematopoietic cells and is involved in apoptosis [40].
THBS1 is a matricellular protein that functions in cell–cell
and cell–matrix adhesion and is down-regulated in a number
of human cancers. THBS1 possesses both anti-proliferative
and anti-angiogenic activity [28,41]. Angiogenesis is a hall-
mark of KS tumors, and the inhibition of THBS1 would aid
not only this process but also proliferation of KSHV-infected
endothelial-derived KS tumor cells. Interestingly, Tarabolleti
et al. reported that THBS1 expression is suppressed in KS
lesions [22]. However, to date, this observation has not been
linked to viral protein expression in KS lesions. THBS1 is also
a strong immune stimulator that can recruit monocytes to
sites of vascular injury [42] and regulate T cell migration
through extracellular matrix [43]. Thus, down-regulation of
THBS1 may also aid in immune evasion of KSHV-infected
cells. While such connections are tempting, we realize the
limitations of examining the effects of viral miRNAs on a
single cell line. However, 293 cells support both latent and
lytic KSHV infection in vitro, and their high transfection
efﬁciency permitted experimental conﬁrmation of a limited
number of targets by using miRNA-speciﬁc reporter assays.
Figure 4. THBS1 Is Targeted by Multiple KSHV miRNAs
(A) Luciferase de-repression assays were performed in 293 pmiRNA
cluster cells with 200 ng of THBS1 39UTR luciferase sensor vector and 400
pmol of individual 29OMe RNAs as indicated. Lysates were assayed at 72
h. The number of miRanda-predicted high affinity binding sites for each
miRNA are listed below.
(B) The same luciferase de-repression assays were performed as in (A)
except with 200 ng of HS6ST2 39UTR luciferase sensor vector.
doi:10.1371/journal.ppat.0030065.g004
Figure 5. Decreased THBS1 Protein Levels Translate into Reduced TGF-b
Activity
Luciferase reporters containing Smad binding sites (SBE4) or the MMP-9
promoter (200 ng) were transfected into 293 pmiRNA cluster or 293
pcDNA control cells and analyzed for luciferase activity at 72 h.
doi:10.1371/journal.ppat.0030065.g005
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Cellular Targets for KSHV MicroRNAsWe have also shown that THBS1 is inhibited in a lymphoid
cell line, BJAB, in a transient assay, indicating that our results
are not restricted to the 293 cell line.
In conclusion, this study yielded a starting list of potential
KSHV miRNA targets, which warrants a further detailed
analysis in all cell types infected with KSHV in vivo
(lymphoid, epithelial, and endothelial cells). Our approach
to identify miRNA targets by ectopic expression, gene
expression proﬁling, reporter assays, and bio-statisticial
analysis has revealed cellular targets with potential roles in
KS biology. These data strongly suggest that virally encoded
m i R N A sm a yd i r e c t l yc o n t r i b u t et op a t h o g e n e s i sa n d
potentially tumorigenesis in the infected host.
Materials and Methods
Plasmid construction, expression vectors, and miRNA sensor
vectors. For generation of pmiRNA cluster, a region from 119,635
to 122,481 nt within the KSHV genome [44] was ampliﬁed from
BCBL-1 genomic DNA and inserted into pcDNA3.1/V5/HisA (Invi-
trogen, http://www.invitrogen.com). For plasmids expressing individ-
ual miRNAs, a region of approximately 200 nts surrounding each pre-
miRNA hairpin was ampliﬁed from the cluster-containing plasmid
and inserted into pcDNA3.1/V5/HisA. Stable 293 cell lines were
generated by Effectene (Qiagen, http://www.qiagen.com) transfections
followed by G418 selection for 4 wk at 100 lg/ml.
Luciferase reporter plasmids were created using the pGL3
promoter vector from Promega (http://www.promega.com). Synthetic
oligonucleotides containing two complete complimentary copies of a
miRNA sequence separated by a 9-bp-long spacer were inserted into
the 39UTR of the luciferase gene upstream of the poly-adenylation
signal. All primer sequences are annotated in Table S2.
Reporter assays using miRNA sensor vectors and 29OMe RNA.
Lipofectamine 2000 (Invitrogen) was used to transfect luciferase
reporter constructs with or without miRNA expressing vectors or
29OMe RNA (Dharmacon, http://www.dharmacon.com) complemen-
tary to a miRNA of interest. Next, 4 310
5 cells were seeded into a 6-
well plate, transfected, and then incubated for 72 h. Cells were lysed
with 250 lL of Cell Lysis Buffer (Promega) and 10 lL of lysate assayed
for luciferase activity (Promega). Light units are normalized to total
protein, determined using the BCA protein assay kit (Pierce, http://
www.piercenet.com) according to manufacturer’s instructions. All
transient transfection experiments were performed twice in tripli-
cate.
Affymetrix array-based gene expression proﬁling. Microarray
experiments were performed using 293 cells stably transfected with
p m i R N Ac l u s t e ro rv e c t o rc o n t r o l .F o re a c hc e l ll i n e ,f o u r
independent cultures of 10-cm plates at 80% conﬂuence were used
for RNA isolation.
RNA isolation was performed using the RNeasy kit as directed by
the manufacturer (Qiagen). RNA was labeled using the GeneChip
Eukaryotic One-Cycle Target Labeling Assay as directed by Affyme-
trix (http://www.affymetrix.com). Labeled target cRNA was used to
interrogate Affymetix U133 2.0 plus human GeneChips that were
hybridized for 16 h at 45 8C. After hybridization, the chips were
washed and stained using Affymetrix ﬂuidics protocol EukGE-
WS2v5_450.
Arrays were scanned with an Affymetrix GeneChip 3000 scanner
and normalization of signal intensity was performed using dChip [45].
The expression level was modeled using the perfect match only
model.
Probe sets whose hybridization signal intensities exhibited a
signiﬁcant difference (p , 0.001 using a random variance model)
between pmiRNA cluster and pcDNA control cells were identiﬁed
using algorithms implemented in BRB ArrayTools developed by Dr.
Richard Simon and Amy Peng Lam (http://linus.nci.nih.gov/
BRB-ArrayTools.html). A hierarchical clustering algorithm was used
to visually display the expression proﬁles of the probe sets found to
be signiﬁcant between the groups.
qRT-PCR, Northern, and Western blot analysis. RNA was reverse-
transcribed using SuperScript III Reverse Transcriptase (Invitrogen)
in the presence of random hexamers according to the manufacturer’s
protocols. qRT-PCR was performed using an Opticon II (MJ Research,
http://www.bio-rad.com) and Dynamo HS SYBR-Green qPCR kit using
cycling conditions as recommended by kit manufacturer (Finnzymes,
http://www.ﬁnnzymes.ﬁ). Primers were designed across exon bounda-
ries using Vector NTI (Invitrogen) and are provided in Table S2. PCR
signals were normalized to b-actin and fold changes reported as 2
DDCt.
For Northern blot analysis, 30 lg of total RNA was loaded onto 12%
8M urea acrylamide gel and transferred onto Genescreen Plus. Probe
labeling was performed using the StarFire oligonucleotide labeling
system (IDT, http://www.idtdna.com).
Immunoblotting was performed as previously described [16]. All
primary antibodies were purchased from Santa Cruz Biotechnology
(http://www.scbt.com). HRP-conjugated secondary antibodies were
purchased from Jackson ImmunoResearch (http://www.
jacksonimmuno.com) and blots were developed with PicoWest
substrate (Pierce).
Bio-statistical data analysis. The 3’UTR sequences of 116 genes
were obtained from Ensembl (http://www.ensembl.org). 39UTRs were
then analyzed to extract all potential miRNA binding sites using an
ad-hoc scanning program speciﬁcally developed to look at seed match
binding. The program looks for occurrences of any number of user-
provided patterns, each of which represents a target for a different
miRNA, and accepts both exact matches or near-exact matches (with
at most one mismatched nucleotide). For each sequence, the program
returns a list containing the positions of the exact matches, and a
second list containing the positions of the near-exact matches and
the position of the mismatched base within each matched subse-
quence.
Supporting Information
Figure S1. All KSHV miRNA Luciferase Sensor Vectors Are
Responsive to Their Respective miRNAs
Luciferase sensor (100 ng) was co-transfected with the noted amounts
of the single miRNA expression vectors. The total amount of DNA
transfected was kept constant with ﬁller pCRII vector (Invitrogen).
Found at doi:10.1371/journal.ppat.0030065.sg001 (536 KB AI).
Figure S2. Distribution of Seed Matches for KSHV miRNAs within the
39UTRs of Analyzed Genes
Using an ad hoc scanning algorithm, the 39UTR of 205 genes were
scanned for seed sequence binding sites of all miRNAs within the
cluster for (A) exact seven nucleotide matches or (B) allowing one
mismatch.
Found at doi:10.1371/journal.ppat.0030065.sg002 (548 KB AI).
Figure S3. mirRanda-Predicted Binding Sites for the KSHV miRNAs
within the 39UTRs of THBS1, ITM2A, SPP1, PRG1, and S100A2
39UTR sequences were obtained from Ensembl. Scans were per-
formed with the following parameters: Gap Open Penalty,  2; Gap
Extend,  8; Score Threshold, 160; Energy Threshold,  12; Scaling
Parameter, 4. Hits were included that either had energy threshold less
than  18 kcal/mol or scores above 190.
Found at doi:10.1371/journal.ppat.0030065.sg003 (73 KB DOC).
Table S1. List of Changed Genes with 100% CV
Found at doi:10.1371/journal.ppat.0030065.st001 (228 KB DOC).
Table S2. List of Primers for the Cloning of miRNA Expression and
Sensor Constructs
Found at doi:10.1371/journal.ppat.0030065.st002 (56 KB DOC).
Accession Numbers
Ensembl (http://www.ensembl.org) accession numbersfor genes listedin
this paper are HS6ST2 (ENST00000370837), ITM2A
(ENST00000373298), PRG1 (ENST00000242465), RAB27A
(ENST00000336787), S100A2 (ENST00000368711), SPP1
(ENST00000237623), and THBS1 (ENST00000260356). The Entrez
Nucelotide (http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?db¼Nucleotide) accession number for the KSHV miRNA cluster
is AY973824. The Gene Expression Omnibus (http://www.ncbi.nlm.nih.
gov/projects/geo)accessionnumberforthe microarraydataisGSE7554.
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